THE BIOTECH GROWTH TRUST PLC (the "Company")
Results of a General Meeting of the Company held on 4th
December 2009
The Company announces that the following resolutions were passed at a General
Meeting of the Company held on Friday, 4th
December 2009 and the level of proxy votes received is shown below.
Resolutions Votes For % Votes % Total Votes
Against Votes Cast
Withheld*
1. The removal of the 35,529,370 99.78 78,609 0.22 35,607,979 4,610
limit on shares that may
be allotted by the
Company. (Ordinary
Resolution)
2. Authority for the 34,519,594 99.87 44,964 0.13 34,564,558 1,048,031
Company to allot shares.
(Ordinary Resolution)
3. The Disapplication of 34,487,709 99.78 76,849 0.22 34,564,558 1,048,031
pre-emption rights.
(Special Resolution)
4. The purchase of the 35,554,079 99.85 53,900 0.15 35,607,979 4,610
Company's own shares.
(Special Resolution)
5. The release of the 35,531,240 99.78 76,739 0.22 35,607,979 4,610
Company from its
continuation vote in
2010. (Special
Resolution)
* Please note that `Vote withheld' is not a vote in law and is not counted in
the calculation of the proportion of votes `For' and `Against `a resolution.
- ENDS-
4th December 2009
Frostrow Capital LLP
Secretary
For further information please contact:
Mark Pope Frostrow Capital LLP - 020 3 008
Company Secretary 4913
S:\BIOG\Project Nimble\BIOG Announcement Results of GM 4 Dec 2009 announcement
to UKLA.doc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.